Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | SARS-CoV-2 | Research

The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway

Authors: Merete Ellingjord-Dale, Karl Trygve Kalleberg, Mette S. Istre, Anders B. Nygaard, Sonja H. Brunvoll, Linn M. Eggesbø, John Arne Dahl, Eyrun F. Kjetland, Giske Ursin, Arne Søraas

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

For many people public transport is the only mode of travel, and it can be challenging to keep the necessary distances in such a restricted space. The exact role of public transportation and risk of SARS-CoV-2 transmission is not known.

Methods

Participants (n = 121,374) were untested adult Norwegian residents recruited through social media who in the spring of 2020 completed a baseline questionnaire on demographics and the use of public transport. Incident cases (n = 1069) had a positive SARS-CoV-2 polymerase chain reaction test registered at the Norwegian Messaging System for Infectious Diseases by January 27, 2021. We investigated the association between the use of public transport and SARS-CoV-2 using logistic regression. Odds ratios (ORs) with 95% confidence intervals (CIs) adjusted for age, calendar time, gender, municipality, smoking, income level, fitness and underlying medical conditions were estimated. Frequency of the use of public transport was reported for 2 week-periods.

Results

Before lockdown, those who tested positive on SARS-CoV-2 were more likely to have used public transport 1–3 times (OR = 1.28, CI 1.09–1.51), 4–10 times (OR = 1.49, CI 1.26–1.77) and ≥ 11 times (OR = 1.50, CI 1.27–1.78, p for trend < 0.0001) than those who had not tested positive.

Conclusion

The use of public transport was positively associated with contracting SARS-CoV-2 both before and after lockdown.
Appendix
Available only for authorised users
Literature
10.
go back to reference Aschengrau A, Seage III, GR. Essentials of epidemiology in public health. 2nd edn, 2008. Aschengrau A, Seage III, GR. Essentials of epidemiology in public health. 2nd edn, 2008.
11.
go back to reference Szklo M, Nieto FJ. Epidemiology: beyond the Basics. 4th edn, (Jones & Bartlett Learning, 2018). Szklo M, Nieto FJ. Epidemiology: beyond the Basics. 4th edn, (Jones & Bartlett Learning, 2018).
19.
go back to reference Zhen J, et al. Transmission of respiratory viruses when using public ground transport: a rapid review to inform public health recommendations during the COVID-19 pandemic. S Afr Med J. 2020;110:478–83.PubMed Zhen J, et al. Transmission of respiratory viruses when using public ground transport: a rapid review to inform public health recommendations during the COVID-19 pandemic. S Afr Med J. 2020;110:478–83.PubMed
Metadata
Title
The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway
Authors
Merete Ellingjord-Dale
Karl Trygve Kalleberg
Mette S. Istre
Anders B. Nygaard
Sonja H. Brunvoll
Linn M. Eggesbø
John Arne Dahl
Eyrun F. Kjetland
Giske Ursin
Arne Søraas
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
SARS-CoV-2
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07233-5

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.